DAX
±0,00
%
Gold
±0,00
%
BörsenNEWS.de
Home
Börse
Märkte
Trends
Aktien
Indizes
Rohstoffe
Crypto
Derivate
Analyse
Niedrigstes KGV
Beste Dividende
Marktkapitalisierung
Meistgehandelt
Beste Performance
Termine
Handelskalender
Verfallstage
Community
Foren Übersicht
Meistdiskutiert
Community
News
Aktien
Indizes
Rohstoffe
Fonds
Anleihen
Zertifikate
Optionsscheine
Devisen
Crypto
News
Schlagzeilen
Nachrichten
Community
Meldungen
DAX-News
Dow Jones-News
MDAX-News
Märkte
Aktien
Indizes
Rohstoffe
Devisen
Partner
Archiv
KI-Fragen
Suche
SMARTBROKER
+
Depot
Suche
BörsenNEWS.de
Home
Suche
Suche
Sofort finden was Sie suchen
Alles
News
Aktie
News
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
News
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
News
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
News
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
News
Relief Therapeutics Announces CEO Transition
Aktie
RELIEF THERAPEUTICS Holding
US7595JP2053
4,40
EUR
-20,22
%
News
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
News
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
Aktie
RELIEF THERAPEUTICS Holding AG Registered Shs
US7595JP3044
1,31
USD
-6,47
%
News
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
News
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
News
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
News
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
News
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
News
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
News
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
News
Relief Therapeutics Announces CEO Transition
News
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
News
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
News
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
News
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
News
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
Aktie
RELIEF THERAPEUTICS Holding
US7595JP2053
4,40
EUR
-20,22
%
Aktie
RELIEF THERAPEUTICS Holding AG Registered Shs
US7595JP3044
1,31
USD
-6,47
%
Anmelden
Login
Neu hier?
Jetzt Registrieren
Passwort vergessen?
weiter